Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 715 (USA) (Dr. Moreau)
· consented 2014-02-11
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate APPLICATION SITE REACTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-04-21 (study day 70.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild NAUSEA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-14 (study day 32.0); relationship: REMOTE
mild
assessed
2026-08-18
Mild NAUSEA — outcome: RECOVERED/RESOLVED; onset 2014-03-14 (study day 32.0); relationship: REMOTE
mild
assessed
2026-08-18
Mild SINUS BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-04-22 (study day 71.0); relationship: NONE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.